# A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

> **NCT07734311** · PHASE3 · RECRUITING · sponsor: **Hangzhou Sciwind Biosciences Co., Ltd.** · enrollment: 360 (estimated)

## Conditions studied

- Knee Osteoarthritis
- Obesity

## Interventions

- **DRUG:** Ecnoglutide Injection
- **DRUG:** placebo with matching volume

## Key facts

- **NCT ID:** NCT07734311
- **Lead sponsor:** Hangzhou Sciwind Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07734311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07734311, "A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07734311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*